Nymox shares suspended by Nasdaq, to move to OTC market

Nymox received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained the required $1.00 share price within the six-month extension period granted by Nasdaq, and hence the company’s shares will be suspended from trading on Nasdaq at the open of business on July 7. Nymox shares will be moved to the OTC market. The mechanics of trading the stock remain the same, as do the xompany’s business fundamentals.